Filing Flows › Artivion (AORT) › Q4 2025
Artivion (AORT) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Feb 18, 2026
Artivion (AORT) reported revenue of $116M for the fourth quarter 2025 (Q4 2025), +19% from a year earlier and +2% from the quarter before. Operating margin was 9.2%, net earnings $2.4M (2.1% of revenue).
Artivion, Q4 2025: revenue $116M (+19% year over year), operating margin 9.2%, net earnings $2.4M, operating cash flow $19.6M. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $116M | +2% | +19% |
| Gross profit | $73.1M | -2% | +19% |
| Operating profit | $10.7M | -15% | +300% |
| Net earnings | $2.4M | -63% | — |
| Operating cash flow | $19.6M | -12% | +93% |
What changed
Revenue was $116.0M in Q4 2025, up 19% year over year and up 2% from the previous quarter. Aortic stent grafts was the largest line at 37% of revenue.
Gross margin was 63.1%, down 0.1 points from a year earlier. Operating profit was $10.7M, a 9.2% margin (up 6.5 points year over year). Of the extra revenue versus a year earlier, 43% reached operating profit, above the 3% margin then. Operating expenses grew 6% against revenue growth of 19%. Net earnings were $2.4M. The effective tax rate was 62.9%.
Operating cash flow was $19.6M (up 93% year over year), 806% of net earnings. Non-cash charges added back $5.8M of depreciation and amortization and $4.1M of share-based compensation. Working capital and other items added $7.3M. Capital expenditures of $27.5M exceeded it, leaving free cash flow of −$7.9M.
Questions
What was Artivion's revenue in the fourth quarter 2025?
Artivion (AORT) reported revenue of $116M for the fourth quarter 2025 (Q4 2025), +19% from a year earlier and +2% from the quarter before.
Was Artivion profitable in the fourth quarter 2025?
Operating profit was $10.7M (9.2% of revenue) and net earnings $2.4M.
Source: Artivion 10-K on SEC EDGAR.